The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
cladribine
A purine nucleoside antimetabolite analogue. Cladribine triphosphate, a phosphorylated metabolite of cladribine, incorporates into DNA, resulting in single-strand breaks in DNA, depletion of nicotinamide adenine dinucleotide (NAD) and adenosine triphosphate (ATP), and apoptosis. Because this agent is resistant to adenosine deaminase, an enzyme that inactivates some antineoplastic agents, it is selectively toxic to lymphocytes and monocytes which exhibit little deoxynucleotide deaminase activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | Cladribina | |
| |||
| US brand name: | | Leustatin | |
| |||
| Foreign brand names: | | Leustat Leustatine | |
| |||
| Abbreviations: | | 2CDA 2-CdA | |
| |||
| Code name: | | RWJ-26251 | |
| |||
| Chemical structures: | | 2-chloro-2-deoxyadenosine 2-chlorodeoxyadenosine | |
| |||
